Anti-ferroptotic functions include MFN1-mediated mitochondrial fusion, which reduces ferroptosis sensitivity in cancer cells, as well as the activation of stress response pathways via DELE1 and ATF4, which enhance GSH synthesis and GPX4 stability (37). Here, GPX4 is linked to cancer.